a:5:{s:8:"template";s:1952:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<title>{{ keyword }}</title>
</head>
<style rel="stylesheet" type="text/css">@charset "UTF-8";a,body,div,h1,h2,html{border:0;font-family:inherit;font-size:100%;font-style:inherit;font-weight:inherit;margin:0;outline:0;padding:0;vertical-align:baseline;word-break:break-word}html{font-size:62.5%;overflow-y:scroll;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}*{-webkit-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;box-sizing:border-box}body{background:#fff}article,header,main{display:block}a:active,a:focus,a:hover{outline:0}body{color:#333;font-family:Montserrat,sans-serif;font-size:14px;line-height:1.5;font-weight:400;text-rendering:optimizeLegibility;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}h1{font-size:36px}h2{font-size:30px}h1,h2{font-weight:700}hr{background-color:#ccc;border:0;height:1px;margin-bottom:15px}a{color:#000;text-decoration:none;transition:all .3s ease-in-out;-webkit-transition:all .3s ease-in-out;-moz-transition:all .3s ease-in-out}a:hover{color:#000}#primary{float:left;width:65.5%}.post{margin-bottom:40px;display:inline-block}.entry-meta{font-size:12px;margin-top:12px}.blog .entry-content-block{width:100%}.entry-content-block .entry-title{font-size:18px}.post{width:100%}.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}.has-drop-cap:not(:focus):after{content:"";display:table;clear:both;padding-top:14px}</style>
<body class="">
<div id="page">
<div id="header" role="banner">
<div id="headerimg">
<h1><a href="#">{{ keyword }}</a></h1>
</div>
</div>
<hr/>
{{ text }}
<br>
<br>
{{ links }}
<hr/>
<div id="footer" role="contentinfo">
<p>
{{ keyword }} 2021</p>
</div>
</div>
</body>
</html>";s:4:"text";s:20114:"Today, you can download 7 Best Stocks for the Next 30 Days. The Companyâ€™s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. One stock that might be an intriguing choice for investors right now is GenMark Diagnostics, Inc. GNMK.This is because this security in the Medical - Instruments space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. GenMark Diagnostics Inc., GNMK, GNMK stock, NASDAQ:GNMK The rating was released on August 05, 2020. Find the latest GenMark Diagnostics, Inc. (GNMK) stock quote, history, news and other vital information to help you with your stock trading and investing. The eSensor® XT-8 system is the second generation in GenMark Dx's eSensor® platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. 3 and the Schedule TO relate to the offer by Purchaser to purchase all outstanding shares of common stock, par value $0.0001 per share … GenMark (NASDAQ: GNMK) stock rose 13% after the Food and Drug Administration granted emergency authorization for … Share Price Change. at the time the offer is … We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. GuruFocus has detected 3 severe warning signs with GenMark Diagnostics Inc. . GenMark Diagnostics Inc. [GNMK]: An insightful look at the core fundamentals. Shares of the U.S.-based molecular diagnostic test … 03/16/21-4:01AM EST Zacks Roche (RHHBY) Inks Deal to Acquire GenMark Diagnostics for $1.8B GNMK stock has strong institutional ownership, with … The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to … GNMK stock forecast Our latest prediction for GenMark Diagnostics Inc's stock price was made on the Jan. 25, 2021 when the stock price was at 15.45$.. GenMark Diagnostics Inc Stock Price, News and Company Updates. Management will hold a conference call to review the company's. The price of the stock has decreased by 12.92% since. The high price target for GNMK is … GNMK updated stock price target summary. GenMark Diagnostics Inc. (NASDAQ:GNMK) went up by 0.21% from its latest closing price compared to the recent 1-year high of $24.25. GenMark Diagnostics (GNMK) 1 Month Share Price History. Operating Margin for any stock indicates how profitable investing would be, and GenMark Diagnostics Inc. [GNMK] shares currently have an operating margin of -47.50 and a Gross Margin at +32.50. Score: -10.0. Post-Market 0.06 (0.25%) GNMK stock is soaring as a result. Share Price % Change. April 22, 2021 - 1:00 am. Quite obviously, six months is a short duration for an in-depth analysis. GenMark Diagnostics, Inc (GenMark Diagnostics, Inc is up Monday morning, with the stock rising 29.30% in pre-market trading to 23.92.GNMK's short-term technical score of 69 indicates that the stock has traded more bullishly over the last month than 69% of stocks on the market.  View our latest analysis for GenMark Diagnostics . Company profile page for GenMark Diagnostics Inc including stock price, company news, press releases, executives, board members, and contact information GenMark Diagnostics currently has 5 hold ratings from Wall Street analysts. GenMark Diagnostics has 437 employees across 33 locations and $171.55 M in annual revenue in FY 2020. Shares Traded. It is usually referred to as NASDAQ:GNMK or GNMK-Q Is GenMark Diagnostics a buy or a sell? Provided by PR Newswire Mar 15, 2021 2:23 PM UTC Cowen & Co. The potential in GenMark Diagnostics stock is the rising demand for diagnostic testing as costs decline. GNMK stock is soaring as a result. The stock currently has a share float of 103.16%. GenMark Diagnostics, Inc (NASDAQ:GNMK) shares haven’t seen a lot of action during the third quarter. One stock that might be an intriguing choice for investors right now is GenMark Diagnostics, Inc. GNMK.This is because this security in the Medical - … CARLSBAD, Calif. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market close on Thursday, February 25, 2021. February 11, 2021. Description: Get the latest GenMark Diagnostics, Inc. (GNMK) stock news and headlines to stay up to date and make informed investing and trading decisions. Beta is a measure of a share's volatility in relation to the market. Mr. Gleeson remained an integral part of GenMark’s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. (RTTNews) - Roche (RHHBY) said it plans to complete the acquisition of GenMark Diagnostics Inc. (GNMK), later Thursday. Following completion of the acquisition, GenMark will become a wholly owned subsidiary of Roche, and GenMark's shares will cease to be traded on the NASDAQ Stock Market. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst. Investors in GenMark Diagnostics, Inc.GNMK need to pay close attention to the stock based on moves in the options market lately. In the short term (2weeks), GNMK's stock price should underperform the market by -2.10%.During that period the price should oscillate between -10.01% and +8.61%.. GenMark Diagnostics is a American stock, trading under the symbol GNMK-Q on the NASDAQ (GNMK). GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional … Economies.com provides you with GenMark Diagnostics Inc share price (GNMK) listed in the stock exchange, including the low, high, opening and closing price. GenMark Diagnostics, Inc (NASDAQ:GNMK) shares haven’t seen a lot of action during the third quarter. 8 Stocks That Will Hit All-Time Lows in 2018. GenMark Diagnostics Inc Stock Price, News and Company Updates. Date. Upon looking at major shareholders, it appears that insiders hold 4.29% of GenMark Diagnostics, Inc. shares, and 98.73% of them are in the hands of institutional investors. The stock had previously closed at $15.11. Apollo Endosurgery (NASDAQ:APEN) and GenMark Diagnostics (NASDAQ:GNMK) are both small-cap medical companies, but which is the superior stock? Share Price. Learn More. Benzinga - Mar 17, 2021, 6:48AM. Read or listen to the conference call. The company, currently valued at $995Million, closed the last trade at $14 per share which meant it lost -$0.09 on the day or -0.64% during that session. 11 Jun 2021. GNMK Stock Message Board for Investors. GenMark Diagnostics Stock Forecast NASDAQ: GNMK. A high-level overview of GenMark Diagnostics, Inc. (GNMK) stock. Thanks to fractional shares, you can buy GenMark Diagnostics, Inc. stock in any dollar amount, or any other fund or stock you know on Stash. Start finding winning trades in minutes with Trade Ideas!. GenMark Diagnostics Inc. [GNMK]: Deeper insight into the fundamentals. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA) Roche and GenMark Diagnostics said that Roche's wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly … GenMark Diagnostics just received emergency approval for its coronavirus test panel. The stock price of GenMark Diagnostics, Inc (NASDAQ: GNMK) is trading at over 25% pre-market. GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. GenMark has a market cap of $56.1 million and is part of the health care Investors are responding to the company announcing that they have entered into a definitive merger agreement for Roche to fully acquire GenMark at … 1.6%. The stock was on the rise again yesterday after the company released impressive pre-earnings sales results. GenMark Diagnostics is a member of our Medical group, which includes 903 different companies and currently sits at #5 in the Zacks Sector Rank. Shares of GenMark Diagnostics rose 6.6% in Tuesday’s pre-market trading as the company announced an 84% year-over-year jump in its preliminary fourth-quarter revenue to about $50 million. Showing 1–10 of 13 comments. Press Release reported on 04/05/21 that SHAREHOLDER ALERT: WeissLaw LLP Reminds RMBL, STAY, GNMK, and SLGG Shareholders About Its Ongoing … Stocks making the biggest moves after hours: GenMark Diagnostics, Nvidia, Zoom Video & more. GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GuruFocus.com … GenMark Diagnostics (NASDAQ: GNMK)2:55 PM ET on May 5, 2015. A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GNMK, but not buy more shares or sell existing shares. Start finding winning trades in minutes with Trade Ideas! Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA) GenMark Diagnostics, Inc (GNMK) Up 13.88% in Premarket Trading investorsobserver.com Feb 12, 2021 8:50 am Premarket Mover: GenMark Diagnostics, Inc (GNMK) Down 9.09% GenMark Diagnostics, Inc (NASDAQ: GNMK) is screaming for the top in the premarket this morning.The company is trading on gains of more than 60% after announcing FDA emergency use authorization for its coronavirus diagnostic test.Here’s what’s happening: Stop wasting your time! Trading Signals for Genmark Diagnostics with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. Mr. Mendel served as President and Chief Executive Officer and a member of the board of directors at GenMark Diagnostics, Inc. ("Genmark"), a molecular diagnostics company from May 2020 until its acquisition by Roche in April 2021. 3M 12M Bollinger. See insights on GenMark Diagnostics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. The upgrade of GenMark Diagnostics to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. In the last year, 1 stock analyst published opinions about GNMK-Q. Only 3.25% of the stock of GenMark Diagnostics is held by insiders. GenMark Diagnostics Stock News NASDAQ:GNMK. This report will help you analyze the stock performance of GenMark Diagnostics Inc (GNMK) in the last 6 months. Giulia Petroni. at the time the offer is … Genmark diagnostics (gnmk) stock soars, cowen upgrades. Approximately 914,179 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 2,012,139 shares. Bloomberg stated that GenMark Diagnostics Inc (NASDAQ: GNMK) is reportedly exploring a sale and has been contacted by multiple potential buyers.The company is said to have engaged a … the solicitation and offer to buy genmark diagnostics' common stock will only be made pursuant to an offer to purchase and related materials. GENMARK DIAGNOSTICS INC 0IUT Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals GenMark Diagnostics — GenMark shares popped more than 4% after the Food and Drug Administration granted the company emergency clearance to … The Company’s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. GenMark Diagnostics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. View detailed financial information, real-time news, videos, quotes and analysis on GenMark Diagnostics, Inc. (NASDAQ:GNMK). GenMark Diagnostics, Inc (NASDAQ: GNMK) is making a run for the top in the market this morning, trading on gains of around 20%.The gains come after the company reported preliminary financial data, showing that revenue is seeing strong growth on COVID-19 test demand.Here’s what’s going on: Stop wasting your time! A popular way to gauge a stock's volatility is its "beta". Investors are responding to the company announcing that they have entered into a definitive merger agreement for Roche to fully acquire GenMark at a … GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020. GenMark Diagnostics (GNMK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. GenMark Diagnostics jumped 21% on the stock market today to close at 18.86, extending into profit-taking territory after hitting a buy point in late June. 2/16/2021 – GenMark Diagnostics had its price target raised by analysts at Canaccord Genuity from $22.00 to $24.00. See insights on GenMark Diagnostics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. In depth view into GenMark Diagnostics Preferred Stock Dividend (Quarterly) including historical data from 2010, charts, stats and industry comps. Based on our forecasts, a long-term increase is expected, the "GNMK" stock price prognosis for 2026-04-21 is 43.630 USD. In the past three months, GenMark Diagnostics insiders have sold more of their company’s stock than they have bought. Their average twelve-month price target is $22.01, predicting that the stock has a possible downside of 8.43%. Specifically, they have bought $0.00 in company stock and sold $3,827,857.00 in company stock. Your current $100 investment may be up to $181.49 in 2026. GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. Description. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. GNMK Stock Message Board for Investors. Operating Margin for any stock indicates how profitable investing would be, and GenMark Diagnostics Inc. [GNMK] shares currently have an operating margin of -6.44 and a Gross Margin at +39.61. Message Board Total Posts: 42 Basel, 22 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ: … MARKETS. The stock has a consensus analyst rating of "Hold." the solicitation and offer to buy genmark diagnostics’ common stock will only be made pursuant to an offer to purchase and related materials. Mr. Mendel served as President and Chief Executive Officer and a member of the board of directors at GenMark Diagnostics, Inc. (“Genmark”), a molecular diagnostics company from May 2020 until its acquisition by Roche in April 2021. So far 862,263 shares have traded compared to average volume of 650,473 shares. GenMark now offers 11 company holidays a year! GenMark Diagnostics recorded a solid price appreciation driven by optimism surrounding the buyout deal, wherein the Swiss pharma giant Roche will fully acquire GenMark Diagnostics (at a price of $24.05 per share) in an all-cash transaction worth $1.8 billion. GlobeNewswire 122d. AMD stock was down 1.6%. GenMark Diagnostics is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Find the latest GenMark Diagnostics, Inc. (GNMK) stock quote, history, news and other vital information to help you with your stock trading and investing. $199.43m. The stock information provided is for informational purposes only and is not intended for trading purposes. GenMark Diagnostics Inc quote is equal to 24.040 USD at 2021-06-16. They now have a “buy” rating on the stock. The market (NASDAQ average) beta is 1, while GenMark Diagnostics's is 3.0336. Explore commentary on GenMark Diagnostics, … GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GuruFocus.com 2020-05 … the solicitation and offer to buy genmark diagnostics’ common stock will only be made pursuant to an offer to purchase and related materials. Year In Review 2020 We note that the GenMark Diagnostics, Inc. (NASDAQ:GNMK) President, Scott Mendel, recently sold US$64k worth of stock for US$14.14 per share.However we note that the sale only shrunk their holding by 2.1%. Suggestions. GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the United States. Mr. Mendel has over 25 years of financial and operational leadership experience. GenMark Diagnostics, Inc. NASDAQ Updated May 20, 2021 4:00 AM GNMK 24.04 0.00 (0.00%). GenMark Diagnostics, Inc Has Bright Future as Medical Testing Costs Fall A key player in the molecular diagnostic solutions space is GenMark Diagnostics, Inc (NASDAQ:GNMK). Overall, hedge fund sentiment was unchanged. This suggests that the stock has a possible downside of 8.4%. 5 Wall Street analysts have issued ratings and price targets for GenMark Diagnostics in the last 12 months. GenMark’s ePlex: The True Sample-to-Answer Solution ® is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. Data Provided by Refinitiv. Minimum 15 minutes delayed. GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company’s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics (NASDAQ: GNMK) announced that they have entered into a definitive merger agreement for Roche to fully acquire GenMark at a price of US$ 24.05 per share in an all-cash transaction. GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its sensor detection technology. GenMark Diagnostics, Inc. Why Co-Diagnostics, GenMark, Luminex, and Opko Stocks Are Sinking Today GenMark Diagnostics Inc (GNMK) Q2 2020 Earnings Call Transcript Why GenMark Diagnostics Stock … Volume today is above average. Why Fulgent Genetics Is a Great Stock to Buy Right Now The Motley Fool • Mar 31, 2021 Roche Begins Tender Offer For GenMark Diagnostics For $24.05/shr In Cash RTTNews • Mar 25, 2021 More Articles. The stock price of GenMark Diagnostics, Inc (NASDAQ: GNMK) is trading at over 25% pre-market. Respiratory Pathogen Panels. Roche Holding AG said Monday that it signed a definitive merger agreement with GenMark Diagnostics Inc. in a deal valued at … Employee Benefit Reviews. Thinking about buying stock in Check Cap, Shaw Comm., Acer Therapeutics, Intec Pharma, or GenMark Diagnostics? Company Name: GenMark Diagnostics Inc., Stock Symbol: GNMK, Industry: Medical - Equipment, Total Posts: 249, Last Post: 5/2/2021 6:27:39 PM GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its sensor detection technology. GenMark Diagnostics (GNMK) – GenMark will be bought by Swiss drugmaker Roche for $1.8 billion in cash, or $24.05 per share. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ";s:7:"keyword";s:25:"genmark diagnostics stock";s:5:"links";s:1094:"<a href="https://royalspatn.adamtech.vn/71p88/describe-direct-billing">Describe Direct Billing</a>,
<a href="https://royalspatn.adamtech.vn/71p88/cookie-monster-and-elmo-drawing">Cookie Monster And Elmo Drawing</a>,
<a href="https://royalspatn.adamtech.vn/71p88/time-lapse-software-for-windows-7">Time-lapse Software For Windows 7</a>,
<a href="https://royalspatn.adamtech.vn/71p88/as-you-think%2C-so-shall-you-be-proverbs">As You Think, So Shall You Be Proverbs</a>,
<a href="https://royalspatn.adamtech.vn/71p88/%2B-6moreupscale-drinksmesh-louisville%2C-napa-river-grill%2C-and-more">+ 6moreupscale Drinksmesh Louisville, Napa River Grill, And More</a>,
<a href="https://royalspatn.adamtech.vn/71p88/self-confidence-picture">Self Confidence Picture</a>,
<a href="https://royalspatn.adamtech.vn/71p88/occupation-of-the-sudetenland">Occupation Of The Sudetenland</a>,
<a href="https://royalspatn.adamtech.vn/71p88/warrior-covert-qr-edge-kick-point">Warrior Covert Qr Edge Kick Point</a>,
<a href="https://royalspatn.adamtech.vn/71p88/danish-order-of-knighthood">Danish Order Of Knighthood</a>,
";s:7:"expired";i:-1;}